SG11201608710TA - Anti-enterovirus 71 thiadiazolidine derivative - Google Patents
Anti-enterovirus 71 thiadiazolidine derivativeInfo
- Publication number
- SG11201608710TA SG11201608710TA SG11201608710TA SG11201608710TA SG11201608710TA SG 11201608710T A SG11201608710T A SG 11201608710TA SG 11201608710T A SG11201608710T A SG 11201608710TA SG 11201608710T A SG11201608710T A SG 11201608710TA SG 11201608710T A SG11201608710T A SG 11201608710TA
- Authority
- SG
- Singapore
- Prior art keywords
- enterovirus
- thiadiazolidine
- derivative
- thiadiazolidine derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410176161 | 2014-04-28 | ||
CN201410543064.6A CN105085512A (en) | 2014-04-28 | 2014-10-14 | Enteric virus 71 (EV71)-resistant thiadiazolidine derivatives |
CN201510182757 | 2015-04-16 | ||
PCT/CN2015/077043 WO2015165340A1 (en) | 2014-04-28 | 2015-04-21 | Anti-enterovirus 71 thiadiazolidine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201608710TA true SG11201608710TA (en) | 2016-11-29 |
Family
ID=56755307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201608710TA SG11201608710TA (en) | 2014-04-28 | 2015-04-21 | Anti-enterovirus 71 thiadiazolidine derivative |
Country Status (10)
Country | Link |
---|---|
US (1) | US9988361B2 (en) |
EP (1) | EP3138840B1 (en) |
JP (1) | JP6389531B2 (en) |
KR (2) | KR20160147010A (en) |
CN (1) | CN106661009B (en) |
DK (1) | DK3138840T3 (en) |
ES (1) | ES2841418T3 (en) |
MY (1) | MY176508A (en) |
SG (1) | SG11201608710TA (en) |
TW (1) | TWI658037B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2835061T3 (en) * | 2015-10-26 | 2021-06-21 | Jiangsu Kanion Pharmaceutical Co Ltd | Salt form and crystalline form of 1,2,5-thiadiazolidine 1,1-dioxide, method of preparation thereof and intermediates |
CN113940918B (en) | 2020-07-17 | 2023-06-02 | 江苏康缘药业股份有限公司 | Pharmaceutical composition and preparation method thereof |
CN114539020B (en) * | 2022-01-17 | 2023-12-08 | 南京迈诺威医药科技有限公司 | Preparation method of 1, 5-dibromo-3, 3-difluoropentane |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9104136D0 (en) * | 1991-02-27 | 1991-04-17 | Merck Sharp & Dohme | Therapeutic agents |
DE4107857A1 (en) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | CYCLIC UREA DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
US5852192A (en) * | 1992-03-11 | 1998-12-22 | Dr. Karl Thomae Gmbh | Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
SK94393A3 (en) * | 1992-09-11 | 1994-08-10 | Thomae Gmbh Dr K | Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those |
GB9715816D0 (en) * | 1997-07-25 | 1997-10-01 | Black James Foundation | Histamine H receptor ligands |
US7019026B1 (en) * | 1999-09-10 | 2006-03-28 | Novo Nordisk A/S | Modulators of Protein Tyrosine Phosphatases (PTPases) |
FR2803298A1 (en) * | 1999-12-30 | 2001-07-06 | Adir | NOVEL LINEAR OR CYCLIC UREAS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US7129359B2 (en) * | 2002-07-09 | 2006-10-31 | National Health Research Institutes | Imidazolidinone compounds |
US6706739B2 (en) * | 2001-08-21 | 2004-03-16 | National Health Research Institute | Imidazolidinone compounds |
AU2003256755A1 (en) * | 2002-07-24 | 2004-02-09 | Ptc Therapeutics, Inc. | Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
US7259174B2 (en) * | 2004-05-25 | 2007-08-21 | National Health Research Institutes | Imidazolidinone compounds |
JP2008506702A (en) * | 2004-07-14 | 2008-03-06 | ピーティーシー セラピューティクス,インコーポレーテッド | Method for treating hepatitis C |
EP1948629A1 (en) * | 2005-10-31 | 2008-07-30 | Janssen Pharmaceutica N.V. | Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
KR20080076916A (en) * | 2005-11-01 | 2008-08-20 | 트랜스테크 파르마, 인크. | Pharmaceutical use of substituted amides |
CA2660201C (en) * | 2006-08-15 | 2016-05-03 | Novartis Ag | Organic compounds |
CA2729663A1 (en) * | 2008-07-02 | 2010-01-07 | Avexa Limited | Compounds having antiviral properties |
WO2010029048A1 (en) * | 2008-09-09 | 2010-03-18 | Sekmed Srl | 1, 2, 5-thiadiazole derivatives useful as immune potentiators |
CN102344416B (en) * | 2010-08-02 | 2015-09-16 | 中国人民解放军军事医学科学院毒物药物研究所 | Pyridazine derivatives and the purposes as Antipicornaviral infection medicine thereof |
CN102485717B (en) * | 2010-12-06 | 2015-12-02 | 中国人民解放军军事医学科学院毒物药物研究所 | Thiazole sulfonamide derivatives and the purposes as Antipicornaviral infection medicine thereof |
KR101332805B1 (en) * | 2011-03-31 | 2013-11-27 | 한국화학연구원 | Derivatives Having Adamantyl Group and Pharmaceutical Acceptable Salts Thereof |
GB201402169D0 (en) * | 2014-02-07 | 2014-03-26 | Isis Innovation | Viral inhibitors |
-
2015
- 2015-04-21 SG SG11201608710TA patent/SG11201608710TA/en unknown
- 2015-04-21 DK DK15786304.4T patent/DK3138840T3/en active
- 2015-04-21 US US15/307,710 patent/US9988361B2/en active Active
- 2015-04-21 KR KR1020167033211A patent/KR20160147010A/en not_active Application Discontinuation
- 2015-04-21 ES ES15786304T patent/ES2841418T3/en active Active
- 2015-04-21 KR KR1020187016595A patent/KR101957178B1/en active IP Right Grant
- 2015-04-21 CN CN201580011272.4A patent/CN106661009B/en active Active
- 2015-04-21 JP JP2016565011A patent/JP6389531B2/en active Active
- 2015-04-21 EP EP15786304.4A patent/EP3138840B1/en active Active
- 2015-04-21 MY MYPI2016703942A patent/MY176508A/en unknown
- 2015-04-27 TW TW104113441A patent/TWI658037B/en active
Also Published As
Publication number | Publication date |
---|---|
MY176508A (en) | 2020-08-12 |
EP3138840B1 (en) | 2020-09-23 |
DK3138840T3 (en) | 2020-12-21 |
EP3138840A4 (en) | 2017-12-20 |
ES2841418T3 (en) | 2021-07-08 |
TW201620885A (en) | 2016-06-16 |
JP6389531B2 (en) | 2018-09-12 |
EP3138840A1 (en) | 2017-03-08 |
KR20180069103A (en) | 2018-06-22 |
JP2017513914A (en) | 2017-06-01 |
TWI658037B (en) | 2019-05-01 |
US20170066732A1 (en) | 2017-03-09 |
US9988361B2 (en) | 2018-06-05 |
CN106661009B (en) | 2019-11-26 |
KR101957178B1 (en) | 2019-03-12 |
CN106661009A (en) | 2017-05-10 |
KR20160147010A (en) | 2016-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201413037D0 (en) | Beyond 10 | |
ZA201704602B (en) | Dihydroindolizinone derivative | |
GB201418612D0 (en) | Umajin 1 | |
IL248772A0 (en) | Cyclohexyl-pyridine derivative | |
SG11201608710TA (en) | Anti-enterovirus 71 thiadiazolidine derivative | |
GB201418846D0 (en) | MicroSub 1 | |
GB201416254D0 (en) | LiftEye 2014 | |
GB201414175D0 (en) | Pris-map 1 | |
GB201418606D0 (en) | Lifteye october 2014 | |
GB201413386D0 (en) | Taggstar 2 | |
GB201413310D0 (en) | Taggstar 2 | |
GB201413313D0 (en) | Kapiche 1 | |
GB201412713D0 (en) | Soundwall 2 | |
GB201408307D0 (en) | Pakaging 22 | |
GB201408330D0 (en) | Pckaging 32 | |
GB201406497D0 (en) | Skytag 2 | |
GB201401037D0 (en) | 54545 | |
GB201408333D0 (en) | Concept 15 | |
GB201408337D0 (en) | Concept 23 | |
GB201408336D0 (en) | Concept 22 | |
GB201408335D0 (en) | Concept 21 | |
GB201408334D0 (en) | Concept 16 | |
GB201408341D0 (en) | Concept 31 | |
GB201408310D0 (en) | Concept 11 | |
GB201408344D0 (en) | Concept 44 |